Global Oral Peptide Drug Market Growth (Status and Outlook) 2022-2028
- LP 4952135
- 88 Pages
- May 2022
- Pharmaceuticals
The United States Oral Peptide Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Oral Peptide Drug market, reaching US$ million by the year 2028. As for the Europe Oral Peptide Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Oral Peptide Drug players cover Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Peptide Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Peptide Drug Market Size 2017-2028
2.1.2 Oral Peptide Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Oral Peptide Drug Segment by Type
2.2.1 Linaclotide
2.2.2 Insulin
2.2.3 Plecanatide
2.2.4 Cyclosporine
2.2.5 Octreotide
2.3 Oral Peptide Drug Market Size by Type
2.3.1 Oral Peptide Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Oral Peptide Drug Market Size Market Share by Type (2017-2022)
2.4 Oral Peptide Drug Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.5 Oral Peptide Drug Market Size by Application
2.5.1 Oral Peptide Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Oral Peptide Drug Market Size Market Share by Application (2017-2022)
3 Oral Peptide Drug Market Size by Player
3.1 Oral Peptide Drug Market Size Market Share by Players
3.1.1 Global Oral Peptide Drug Revenue by Players (2020-2022)
3.1.2 Global Oral Peptide Drug Revenue Market Share by Players (2020-2022)
3.2 Global Oral Peptide Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oral Peptide Drug by Regions
4.1 Oral Peptide Drug Market Size by Regions (2017-2022)
4.2 Americas Oral Peptide Drug Market Size Growth (2017-2022)
4.3 APAC Oral Peptide Drug Market Size Growth (2017-2022)
4.4 Europe Oral Peptide Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Oral Peptide Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Oral Peptide Drug Market Size by Country (2017-2022)
5.2 Americas Oral Peptide Drug Market Size by Type (2017-2022)
5.3 Americas Oral Peptide Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Peptide Drug Market Size by Region (2017-2022)
6.2 APAC Oral Peptide Drug Market Size by Type (2017-2022)
6.3 APAC Oral Peptide Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oral Peptide Drug by Country (2017-2022)
7.2 Europe Oral Peptide Drug Market Size by Type (2017-2022)
7.3 Europe Oral Peptide Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Peptide Drug by Region (2017-2022)
8.2 Middle East & Africa Oral Peptide Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Oral Peptide Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Oral Peptide Drug Market Forecast
10.1 Global Oral Peptide Drug Forecast by Regions (2023-2028)
10.1.1 Global Oral Peptide Drug Forecast by Regions (2023-2028)
10.1.2 Americas Oral Peptide Drug Forecast
10.1.3 APAC Oral Peptide Drug Forecast
10.1.4 Europe Oral Peptide Drug Forecast
10.1.5 Middle East & Africa Oral Peptide Drug Forecast
10.2 Americas Oral Peptide Drug Forecast by Country (2023-2028)
10.2.1 United States Oral Peptide Drug Market Forecast
10.2.2 Canada Oral Peptide Drug Market Forecast
10.2.3 Mexico Oral Peptide Drug Market Forecast
10.2.4 Brazil Oral Peptide Drug Market Forecast
10.3 APAC Oral Peptide Drug Forecast by Region (2023-2028)
10.3.1 China Oral Peptide Drug Market Forecast
10.3.2 Japan Oral Peptide Drug Market Forecast
10.3.3 Korea Oral Peptide Drug Market Forecast
10.3.4 Southeast Asia Oral Peptide Drug Market Forecast
10.3.5 India Oral Peptide Drug Market Forecast
10.3.6 Australia Oral Peptide Drug Market Forecast
10.4 Europe Oral Peptide Drug Forecast by Country (2023-2028)
10.4.1 Germany Oral Peptide Drug Market Forecast
10.4.2 France Oral Peptide Drug Market Forecast
10.4.3 UK Oral Peptide Drug Market Forecast
10.4.4 Italy Oral Peptide Drug Market Forecast
10.4.5 Russia Oral Peptide Drug Market Forecast
10.5 Middle East & Africa Oral Peptide Drug Forecast by Region (2023-2028)
10.5.1 Egypt Oral Peptide Drug Market Forecast
10.5.2 South Africa Oral Peptide Drug Market Forecast
10.5.3 Israel Oral Peptide Drug Market Forecast
10.5.4 Turkey Oral Peptide Drug Market Forecast
10.5.5 GCC Countries Oral Peptide Drug Market Forecast
10.6 Global Oral Peptide Drug Forecast by Type (2023-2028)
10.7 Global Oral Peptide Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Oral Peptide Drug Product Offered
11.1.3 Allergan Oral Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk Oral Peptide Drug Product Offered
11.2.3 Novo Nordisk Oral Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Synergy Pharmaceuticals （Salix）
11.3.1 Synergy Pharmaceuticals （Salix） Company Information
11.3.2 Synergy Pharmaceuticals （Salix） Oral Peptide Drug Product Offered
11.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Synergy Pharmaceuticals （Salix） Main Business Overview
11.3.5 Synergy Pharmaceuticals （Salix） Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Oral Peptide Drug Product Offered
11.4.3 Novartis Oral Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Chiasma
11.5.1 Chiasma Company Information
11.5.2 Chiasma Oral Peptide Drug Product Offered
11.5.3 Chiasma Oral Peptide Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Chiasma Main Business Overview
11.5.5 Chiasma Latest Developments
12 Research Findings and Conclusion
Table 1. Oral Peptide Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Linaclotide
Table 3. Major Players of Insulin
Table 4. Major Players of Plecanatide
Table 5. Major Players of Cyclosporine
Table 6. Major Players of Octreotide
Table 7. Oral Peptide Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Oral Peptide Drug Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Oral Peptide Drug Market Size Market Share by Type (2017-2022)
Table 10. Oral Peptide Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Oral Peptide Drug Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Oral Peptide Drug Market Size Market Share by Application (2017-2022)
Table 13. Global Oral Peptide Drug Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Oral Peptide Drug Revenue Market Share by Player (2020-2022)
Table 15. Oral Peptide Drug Key Players Head office and Products Offered
Table 16. Oral Peptide Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oral Peptide Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Oral Peptide Drug Market Size Market Share by Regions (2017-2022)
Table 21. Americas Oral Peptide Drug Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Oral Peptide Drug Market Size Market Share by Country (2017-2022)
Table 23. Americas Oral Peptide Drug Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Oral Peptide Drug Market Size Market Share by Type (2017-2022)
Table 25. Americas Oral Peptide Drug Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Oral Peptide Drug Market Size Market Share by Application (2017-2022)
Table 27. APAC Oral Peptide Drug Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Oral Peptide Drug Market Size Market Share by Region (2017-2022)
Table 29. APAC Oral Peptide Drug Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Oral Peptide Drug Market Size Market Share by Type (2017-2022)
Table 31. APAC Oral Peptide Drug Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Oral Peptide Drug Market Size Market Share by Application (2017-2022)
Table 33. Europe Oral Peptide Drug Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Oral Peptide Drug Market Size Market Share by Country (2017-2022)
Table 35. Europe Oral Peptide Drug Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Oral Peptide Drug Market Size Market Share by Type (2017-2022)
Table 37. Europe Oral Peptide Drug Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Oral Peptide Drug Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Oral Peptide Drug Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Oral Peptide Drug Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Oral Peptide Drug Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Oral Peptide Drug Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Oral Peptide Drug Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Oral Peptide Drug Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Oral Peptide Drug
Table 46. Key Market Challenges & Risks of Oral Peptide Drug
Table 47. Key Industry Trends of Oral Peptide Drug
Table 48. Global Oral Peptide Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Oral Peptide Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Oral Peptide Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Oral Peptide Drug Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Oral Peptide Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Oral Peptide Drug Market Size Market Share Forecast by Application (2023-2028)
Table 54. Allergan Details, Company Type, Oral Peptide Drug Area Served and Its Competitors
Table 55. Allergan Oral Peptide Drug Product Offered
Table 56. Allergan Oral Peptide Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Allergan Main Business
Table 58. Allergan Latest Developments
Table 59. Novo Nordisk Details, Company Type, Oral Peptide Drug Area Served and Its Competitors
Table 60. Novo Nordisk Oral Peptide Drug Product Offered
Table 61. Novo Nordisk Main Business
Table 62. Novo Nordisk Oral Peptide Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Novo Nordisk Latest Developments
Table 64. Synergy Pharmaceuticals （Salix） Details, Company Type, Oral Peptide Drug Area Served and Its Competitors
Table 65. Synergy Pharmaceuticals （Salix） Oral Peptide Drug Product Offered
Table 66. Synergy Pharmaceuticals （Salix） Main Business
Table 67. Synergy Pharmaceuticals （Salix） Oral Peptide Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Synergy Pharmaceuticals （Salix） Latest Developments
Table 69. Novartis Details, Company Type, Oral Peptide Drug Area Served and Its Competitors
Table 70. Novartis Oral Peptide Drug Product Offered
Table 71. Novartis Main Business
Table 72. Novartis Oral Peptide Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Novartis Latest Developments
Table 74. Chiasma Details, Company Type, Oral Peptide Drug Area Served and Its Competitors
Table 75. Chiasma Oral Peptide Drug Product Offered
Table 76. Chiasma Main Business
Table 77. Chiasma Oral Peptide Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Chiasma Latest Developments
List of Figures
Figure 1. Oral Peptide Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Peptide Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Oral Peptide Drug Market Size Market Share by Type in 2021
Figure 7. Oral Peptide Drug in Hospital
Figure 8. Global Oral Peptide Drug Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Oral Peptide Drug in Retail Pharmacy
Figure 10. Global Oral Peptide Drug Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Global Oral Peptide Drug Market Size Market Share by Application in 2021
Figure 12. Global Oral Peptide Drug Revenue Market Share by Player in 2021
Figure 13. Global Oral Peptide Drug Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Oral Peptide Drug Market Size 2017-2022 ($ Millions)
Figure 15. APAC Oral Peptide Drug Market Size 2017-2022 ($ Millions)
Figure 16. Europe Oral Peptide Drug Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Oral Peptide Drug Market Size 2017-2022 ($ Millions)
Figure 18. Americas Oral Peptide Drug Value Market Share by Country in 2021
Figure 19. Americas Oral Peptide Drug Consumption Market Share by Type in 2021
Figure 20. Americas Oral Peptide Drug Market Size Market Share by Application in 2021
Figure 21. United States Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Oral Peptide Drug Market Size Market Share by Region in 2021
Figure 26. APAC Oral Peptide Drug Market Size Market Share by Application in 2021
Figure 27. China Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Oral Peptide Drug Market Size Market Share by Country in 2021
Figure 34. Europe Oral Peptide Drug Market Size Market Share by Type in 2021
Figure 35. Europe Oral Peptide Drug Market Size Market Share by Application in 2021
Figure 36. Germany Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Oral Peptide Drug Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Oral Peptide Drug Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Oral Peptide Drug Market Size Market Share by Application in 2021
Figure 44. Egypt Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Oral Peptide Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 50. APAC Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 51. Europe Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 53. United States Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 54. Canada Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 57. China Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 58. Japan Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 59. Korea Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 61. India Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 62. Australia Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 63. Germany Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 64. France Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 65. UK Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 66. Italy Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 67. Russia Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 68. Spain Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 71. Israel Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Oral Peptide Drug Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
